Skip to main content
Top
Published in: Endocrine 1/2016

01-10-2016 | Endocrine Methods and Techniques

Efficacy of protocols for induction of chronic hyperthyroidism in male and female mice

Authors: Kathrin Engels, Helena Rakov, Denise Zwanziger, Georg Sebastian Hönes, Maren Rehders, Klaudia Brix, Josef Köhrle, Lars Christian Möller, Dagmar Führer

Published in: Endocrine | Issue 1/2016

Login to get access

Abstract

Protocols for induction of hyperthyroidism in mice are highly variable and mostly involve short-term thyroid hormone (TH) treatment. In addition, little is known about a possible influence of sex on experimental TH manipulation. Here we analyzed the efficacy of intraperitoneal vs. oral levothyroxine (T4) administration to induce chronic hyperthyroidism in male and female mice and asked which T4 dosing intervals are required to achieve stable organ thyrotoxicosis. T4 was administered intraperitoneally or orally over a period of 6/7 weeks. Assessment included monitoring of body weight, TH serum concentrations, and serial quantitative TH target gene expression analysis in liver and heart. Our results show that both intraperitoneal and oral T4 treatment are reliable methods for induction of chronic hyperthyroidism in mice. Thereby T4 injection intervals should not exceed 48 h and oral levothyroxine should be administered continuously during experiments and up to sacrifice to ensure a hyperthyroid organ state. Furthermore, we found a sex-dependent variation in levothyroxine-induced TH serum state, with significantly higher T4 concentrations in female mice, while expression of investigated classical TH responsive genes in liver and heart did not vary with animal’s sex. In summary, our study shows that common approaches for rendering rodents thyrotoxic can also be used for induction of chronic hyperthyroidism in male and female mice. Thereby T4 dosing intervals are critical as are read-out parameters to verify a chronic thyrotoxic organ state.
Appendix
Available only for authorised users
Literature
4.
go back to reference C. Meisinger, T. Ittermann, H. Wallaschofski, M. Heier, H. Below, A. Kramer, A. Doring, M. Nauck, H. Volzke, Geographic variations in the frequency of thyroid disorders and thyroid peroxidase antibodies in persons without former thyroid disease within Germany. Eur. J. Endocrinol. 167(3), 363–371 (2012). doi:10.1530/EJE-12-0111 CrossRefPubMed C. Meisinger, T. Ittermann, H. Wallaschofski, M. Heier, H. Below, A. Kramer, A. Doring, M. Nauck, H. Volzke, Geographic variations in the frequency of thyroid disorders and thyroid peroxidase antibodies in persons without former thyroid disease within Germany. Eur. J. Endocrinol. 167(3), 363–371 (2012). doi:10.​1530/​EJE-12-0111 CrossRefPubMed
6.
go back to reference A.C. Bianco, G. Anderson, D. Forrest, V.A. Galton, B. Gereben, B.W. Kim, P.A. Kopp, X.H. Liao, M.J. Obregon, R.P. Peeters, S. Refetoff, D.S. Sharlin, W.S. Simonides, R.E. Weiss, G.R. Williams, American Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models. Thyroid 24(1), 88–168 (2014). doi:10.1089/thy.2013.0109 CrossRefPubMedPubMedCentral A.C. Bianco, G. Anderson, D. Forrest, V.A. Galton, B. Gereben, B.W. Kim, P.A. Kopp, X.H. Liao, M.J. Obregon, R.P. Peeters, S. Refetoff, D.S. Sharlin, W.S. Simonides, R.E. Weiss, G.R. Williams, American Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models. Thyroid 24(1), 88–168 (2014). doi:10.​1089/​thy.​2013.​0109 CrossRefPubMedPubMedCentral
9.
go back to reference S.A. Bustin, V. Benes, J.A. Garson, J. Hellemans, J. Huggett, M. Kubista, R. Mueller, T. Nolan, M.W. Pfaffl, G.L. Shipley, J. Vandesompele, C.T. Wittwer, The MIQE Guidelines: minimum information for publication of quantitative real-time pcr experiments. Clin. Chem. 55(4), 611–622 (2009). doi:10.1373/clinchem.2008.112797 CrossRefPubMed S.A. Bustin, V. Benes, J.A. Garson, J. Hellemans, J. Huggett, M. Kubista, R. Mueller, T. Nolan, M.W. Pfaffl, G.L. Shipley, J. Vandesompele, C.T. Wittwer, The MIQE Guidelines: minimum information for publication of quantitative real-time pcr experiments. Clin. Chem. 55(4), 611–622 (2009). doi:10.​1373/​clinchem.​2008.​112797 CrossRefPubMed
11.
go back to reference K. Hasselstrom, K. Siersbaek-Nielsen, lB. Lumholtz, J. Faber, C. Kirkegaard, T. Friis, : The bioavailability of thyroxine and 3,5,3′-triiodothyronine in normal subjects and in hyper- and hypothyroid patients. Eur. J. Endocrinol. 110(4), 483–486 (1985). doi:10.1530/acta.0.1100483 CrossRef K. Hasselstrom, K. Siersbaek-Nielsen, lB. Lumholtz, J. Faber, C. Kirkegaard, T. Friis, : The bioavailability of thyroxine and 3,5,3′-triiodothyronine in normal subjects and in hyper- and hypothyroid patients. Eur. J. Endocrinol. 110(4), 483–486 (1985). doi:10.​1530/​acta.​0.​1100483 CrossRef
12.
go back to reference T.C. Crowe, N.L. Cowen, N.M. Loidl, D.J. Topliss, J.R. Stockigt, J.W. Barlow, Down-regulation of thyroxine-binding globulin messenger ribonucleic acid by 3,5,3′-triiodothyronine in human hepatoblastoma cells. J. Clin. Endocrinol. Metab. 80(7), 2233–2237 (1995). doi:10.1210/jcem.80.7.7608285 PubMed T.C. Crowe, N.L. Cowen, N.M. Loidl, D.J. Topliss, J.R. Stockigt, J.W. Barlow, Down-regulation of thyroxine-binding globulin messenger ribonucleic acid by 3,5,3′-triiodothyronine in human hepatoblastoma cells. J. Clin. Endocrinol. Metab. 80(7), 2233–2237 (1995). doi:10.​1210/​jcem.​80.​7.​7608285 PubMed
13.
go back to reference L.C. Moeller, A.M. Dumitrescu, S. Refetoff, Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and glycolytic genes. Mol. Endocrinol. 19(12), 2955–2963 (2005). doi:10.1210/me.2004-0542 CrossRefPubMed L.C. Moeller, A.M. Dumitrescu, S. Refetoff, Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and glycolytic genes. Mol. Endocrinol. 19(12), 2955–2963 (2005). doi:10.​1210/​me.​2004-0542 CrossRefPubMed
14.
15.
go back to reference A. Flores-Morales, H. Gullberg, L. Fernandez, N. Ståhlberg, N.H. Lee, B. Vennström, G. Norstedt, Patterns of liver gene expression governed by TRbeta. Mol. Endocrinol. 16(6), 1257–1268 (2002). doi:10.1210/mend.16.6.0846 PubMed A. Flores-Morales, H. Gullberg, L. Fernandez, N. Ståhlberg, N.H. Lee, B. Vennström, G. Norstedt, Patterns of liver gene expression governed by TRbeta. Mol. Endocrinol. 16(6), 1257–1268 (2002). doi:10.​1210/​mend.​16.​6.​0846 PubMed
17.
go back to reference A.J. Klecha, A.M. Genaro, G. Gorelik, M.L. Barreiro Arcos, D.M. Silberman, M. Schuman, S.I. Garcia, C. Pirola, G.A. Cremaschi, Integrative study of hypothalamus-pituitary-thyroid-immune system interaction: thyroid hormone-mediated modulation of lymphocyte activity through the protein kinase C signaling pathway. J. Endocrinol. 189(1), 45–55 (2006). doi:10.1677/joe.1.06137 CrossRefPubMed A.J. Klecha, A.M. Genaro, G. Gorelik, M.L. Barreiro Arcos, D.M. Silberman, M. Schuman, S.I. Garcia, C. Pirola, G.A. Cremaschi, Integrative study of hypothalamus-pituitary-thyroid-immune system interaction: thyroid hormone-mediated modulation of lymphocyte activity through the protein kinase C signaling pathway. J. Endocrinol. 189(1), 45–55 (2006). doi:10.​1677/​joe.​1.​06137 CrossRefPubMed
18.
go back to reference T.D. Reed, G.J. Babu, Y. Ji, A. Zilberman, Mver Heyen, F. Wuytack, M. Periasamy, The expression of SR calcium transport ATPase and the Na(+)/Ca(2+)Exchanger are antithetically regulated during mouse cardiac development and in hypo/hyperthyroidism. J. Mol. Cell. Cardiol. 32(3), 453–464 (2000). doi:10.1006/jmcc.1999.1095 CrossRefPubMed T.D. Reed, G.J. Babu, Y. Ji, A. Zilberman, Mver Heyen, F. Wuytack, M. Periasamy, The expression of SR calcium transport ATPase and the Na(+)/Ca(2+)Exchanger are antithetically regulated during mouse cardiac development and in hypo/hyperthyroidism. J. Mol. Cell. Cardiol. 32(3), 453–464 (2000). doi:10.​1006/​jmcc.​1999.​1095 CrossRefPubMed
19.
go back to reference E. Ferreira, A.E. Silva, R. Serakides, A.E.S. Gomes, G.D. Cassali, Ehrlich tumor as model to study artificial hyperthyroidism influence on breast cancer. Pathol. Res. Pract. 203(1), 39–44 (2007). E. Ferreira, A.E. Silva, R. Serakides, A.E.S. Gomes, G.D. Cassali, Ehrlich tumor as model to study artificial hyperthyroidism influence on breast cancer. Pathol. Res. Pract. 203(1), 39–44 (2007).
20.
go back to reference J.S. Wilcoxon, G.J. Nadolski, J. Samarut, O. Chassande, E.E. Redei, Behavioral inhibition and impaired spatial learning and memory in hypothyroid mice lacking thyroid hormone receptor α. Behav. Brain Res. 177(1), 109–116 (2007). doi:10.1016/j.bbr.2006.10.030 CrossRefPubMed J.S. Wilcoxon, G.J. Nadolski, J. Samarut, O. Chassande, E.E. Redei, Behavioral inhibition and impaired spatial learning and memory in hypothyroid mice lacking thyroid hormone receptor α. Behav. Brain Res. 177(1), 109–116 (2007). doi:10.​1016/​j.​bbr.​2006.​10.​030 CrossRefPubMed
21.
go back to reference M. Messarah, A. Boumendjel, A. Chouabia, F. Klibet, C. Abdennour, M.S. Boulakoud, A.E. Feki, Influence of thyroid dysfunction on liver lipid peroxidation and antioxidant status in experimental rats. Exp. Toxicol. Pathol. 62(3), 301–310 (2010). doi:10.1016/j.etp.2009.04.009 CrossRefPubMed M. Messarah, A. Boumendjel, A. Chouabia, F. Klibet, C. Abdennour, M.S. Boulakoud, A.E. Feki, Influence of thyroid dysfunction on liver lipid peroxidation and antioxidant status in experimental rats. Exp. Toxicol. Pathol. 62(3), 301–310 (2010). doi:10.​1016/​j.​etp.​2009.​04.​009 CrossRefPubMed
Metadata
Title
Efficacy of protocols for induction of chronic hyperthyroidism in male and female mice
Authors
Kathrin Engels
Helena Rakov
Denise Zwanziger
Georg Sebastian Hönes
Maren Rehders
Klaudia Brix
Josef Köhrle
Lars Christian Möller
Dagmar Führer
Publication date
01-10-2016
Publisher
Springer US
Published in
Endocrine / Issue 1/2016
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1020-8

Other articles of this Issue 1/2016

Endocrine 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.